Momcozy Launches Wellness 1 Warm-Massage Wearable Breast Pump Alongside Breathe & Breastfeed Across Southeast Asia

by | PRNewswire Asia

This World Breastfeeding Month, Momcozy  launches the Wellness 1 Warm-Massage Wearable Breast Pump and Breathe & Breastfeed across Southeast Asia, combining innovative breastfeeding technology with expert guidance and community support, supporting mothers...

Ainex's ENAD Chosen for Singapore's National University Hospital After Global Competition

by | PRNewswire Asia

ENAD, Korea’s First and Only AI-Assisted Solution Approved for Both Upper and Lower GI Endoscopy ENAD Secures Singapore Hospital Adoption in Competition with Medtronic, Olympus, and Fujifilm Rapid Market Breakthrough Follows Singapore HSA Approval;...

Kavalan Solist Oloroso Sherry Crowned TWSC 2026 Best of the Best

by | PRNewswire Asia

Kavalan also named Best Asian Distillery of the Year TAIPEI, Aug. 4, 2026 /PRNewswire/ — Kavalan Solist Oloroso Sherry Single Cask Strength Single Malt Whisky has been named Best of the Best Single Malt at the Tokyo Whisky & Spirits Competition (TWSC) 2026,...

Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy

by | PRNewswire Asia

At the Precision Oncology Academy 2026, leading international experts explored how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more confident treatment decisions to improve cancer care. KUALA LUMPUR,...

KPJ Healthcare Launches First Orthopaedic and Rheumatology Centre of Excellence Under the KPJ Health System

by | PRNewswire Asia

BUKIT MERTAJAM, Malaysia, Aug. 4, 2026 /PRNewswire/ — KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Orthopaedic and Rheumatology Centre of Excellence ("CoE") at KPJ Penang Specialist Hospital...

Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination

by | PRNewswire Asia

-Initiated global Phase III program for oral small molecule GLP-1, ASC30, which will enroll approximately 4,600 participants with obesity or overweight across two pivotal trials in the U.S., Europe, and Canada. -Positive preclinical data in non-human primates...